171 related articles for article (PubMed ID: 20151174)
1. A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma.
Massimino M; Spreafico F; Riva D; Biassoni V; Poggi G; Solero C; Gandola L; Genitori L; Modena P; Simonetti F; Potepan P; Casanova M; Meazza C; Clerici CA; Catania S; Sardi I; Giangaspero F
J Neurooncol; 2010 Oct; 100(1):65-71. PubMed ID: 20151174
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment with a low-dose cisplatin--etoposide regimen for patients with diencephalic syndrome.
Sardi I; Bresci C; Schiavello E; Biassoni V; Fratoni V; Cardellicchio S; Genitori L; Aricò M; Massimino M
J Neurooncol; 2012 Sep; 109(2):375-83. PubMed ID: 22717669
[TBL] [Abstract][Full Text] [Related]
3. A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report.
Gnekow AK; Walker DA; Kandels D; Picton S; Giorgio Perilongo ; Grill J; Stokland T; Sandstrom PE; Warmuth-Metz M; Pietsch T; Giangaspero F; Schmidt R; Faldum A; Kilmartin D; De Paoli A; De Salvo GL;
Eur J Cancer; 2017 Aug; 81():206-225. PubMed ID: 28649001
[TBL] [Abstract][Full Text] [Related]
4. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
5. Treatment of paediatric pontine glioma with oral trophosphamide and etoposide.
Wolff JE; Westphal S; Mölenkamp G; Gnekow A; Warmuth-Metz M; Rating D; Kuehl J
Br J Cancer; 2002 Oct; 87(9):945-9. PubMed ID: 12434281
[TBL] [Abstract][Full Text] [Related]
6. Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study.
Ashby LS; Shapiro WR
J Neurooncol; 2001 Jan; 51(1):67-86. PubMed ID: 11349883
[TBL] [Abstract][Full Text] [Related]
7. Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
Rajkumar SV; Buckner JC; Schomberg PJ; Reid JM; Bagniewski PJ; Ames MM; Cascino TL; Marks RS
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):969-75. PubMed ID: 9869217
[TBL] [Abstract][Full Text] [Related]
8. High response rate to cisplatin/etoposide regimen in childhood low-grade glioma.
Massimino M; Spreafico F; Cefalo G; Riccardi R; Tesoro-Tess JD; Gandola L; Riva D; Ruggiero A; Valentini L; Mazza E; Genitori L; Di Rocco C; Navarria P; Casanova M; Ferrari A; Luksch R; Terenziani M; Balestrini MR; Colosimo C; Fossati-Bellani F
J Clin Oncol; 2002 Oct; 20(20):4209-16. PubMed ID: 12377964
[TBL] [Abstract][Full Text] [Related]
9. Low-dose cisplatin-etoposide regimen for patients with optic pathway glioma: a report of four cases and literature review.
Cardellicchio S; Bacci G; Farina S; Genitori L; Massimino M; de Martino M; Caputo R; Sardi I
Neuropediatrics; 2014 Feb; 45(1):42-9. PubMed ID: 24272769
[TBL] [Abstract][Full Text] [Related]
10. Responsiveness of progressive optic pathway tumors to cisplatin-based chemotherapy in children.
Hsu TR; Wong TT; Chang FC; Ho DM; Tang RB; Thien PF; Chang KP
Childs Nerv Syst; 2008 Dec; 24(12):1457-61. PubMed ID: 18769928
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab-containing regimen in relapsed/progressed brain tumors: a single-institution experience.
Schiavetti A; Varrasso G; Mollace MG; Dominici C; Ferrara E; Papoff P; Di Biasi C
Childs Nerv Syst; 2019 Jun; 35(6):1007-1012. PubMed ID: 30903281
[TBL] [Abstract][Full Text] [Related]
12. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y
Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant cisplatin and etoposide, with or without tamoxifen, prior to radiotherapy in high-grade gliomas: a single-center experience.
Díaz R; Jordá MV; Reynés G; Aparicio J; Segura A; Amador R; Calderero V; Beltrán A
Anticancer Drugs; 2005 Mar; 16(3):323-9. PubMed ID: 15711185
[TBL] [Abstract][Full Text] [Related]
14. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
[TBL] [Abstract][Full Text] [Related]
15. Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children.
Osztie E; Várallyay P; Doolittle ND; Lacy C; Jones G; Nickolson HS; Neuwelt EA
AJNR Am J Neuroradiol; 2001 May; 22(5):818-23. PubMed ID: 11337321
[TBL] [Abstract][Full Text] [Related]
16. Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
Urban C; Benesch M; Pakisch B; Lackner H; Kerbl R; Schwinger W; Oberbauer R
J Neurooncol; 1998 Aug; 39(1):71-80. PubMed ID: 9760072
[TBL] [Abstract][Full Text] [Related]
17. Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach.
Kellie SJ; Boyce H; Dunkel IJ; Diez B; Rosenblum M; Brualdi L; Finlay JL
Pediatr Blood Cancer; 2004 Aug; 43(2):126-33. PubMed ID: 15236278
[TBL] [Abstract][Full Text] [Related]
18. Treatment of childhood astrocytomas with irinotecan and cisplatin.
Mora J; Perez-Jaume S; Cruz O
Clin Transl Oncol; 2018 Apr; 20(4):500-507. PubMed ID: 28828715
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149).
Swinnen LJ; Rankin C; Carraway H; Albain KS; Townsend JJ; Budd GT; Kish JA; Rivkin SE; Blumenthal DT
J Neurooncol; 2008 Feb; 86(3):353-8. PubMed ID: 18175205
[TBL] [Abstract][Full Text] [Related]
20. High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors.
Castello MA; Clerico A; Deb G; Dominici C; Fidani P; Donfrancesco A
Am J Pediatr Hematol Oncol; 1990; 12(3):297-300. PubMed ID: 2173440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
